Streck, Inc. and RUWAG Diagnostics, a medical diagnostic and life sciences products distributor in Switzerland, have signed a distribution agreement for Streck’s cell stabilization and molecular products.
Streck’s cell stabilization products include Cell-Free DNA Urine Preserve, a formaldehyde-free liquid reagent that stabilizes cell-free DNA (cfDNA) in urine; Cyto-Chex® BCT, a blood collection tube for the preservation of whole blood specimens for immunophenotyping by flow cytometry; Cell-Free DNA BCT® CE, a direct-draw blood collection tube which stabilizes nucleated blood cells and prevents the release of genomic DNA, allowing isolation of high-quality cell-free DNA for a wide range of downstream applications commonly used in clinical research studies, drug discovery and diagnostic assay development; and Cell-Free RNA BCT® CE, a blood collection tube with a patented preservative which stabilizes circulating RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage. Cell-Free DNA BCT® CE and Cell-Free RNA BCT® CE are for Export Only. Not for sale in the U.S.
Streck’s Molecular Products division is focused on the generation of rapid diagnostic tools that impact healthcare decisions. Streck’s molecular product line includes the ARM-D® Kits for the detection of antibiotic resistance genes by multiplex real-time PCR. In addition, Streck is developing a library of diagnostics tools that will soon be available in Switzerland and the rest of the world.
“We are a distributor of high quality diagnostic and state-of-the-art products of selected manufacturers in the Swiss diagnostics and life science market,” said Daniel Rothenbühler, General Manager of RUWAG. “Our partnership with Streck will help us provide customers with the quality cell stabilization products they need.”
“RUWAG is well established throughout Switzerland and we are pleased to partner with a company that will allow Streck increased market penetration,” said Connie Ryan, President and CEO at Streck. “In addition, RUWAG will be able to provide excellent local support to our European customers.”
RUWAG was founded in 1987 as RUWAG Handels AG and distributes medical diagnostic and life science products in Switzerland. RUWAG is a distributor for reagents, as well as instruments, and is a market leader in autoimmune diagnostics and an important player in infectious disease diagnostics, life science and microbiology automation.
About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck’’’s passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck offers the industry’’’s leading automated erythrocyte sedimentation rate instrument and is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products being developed for the burgeoning field of molecular diagnostics. For more information, visit www.streck.com.